KEGG   DRUG: Ocaratuzumab
Entry
D10482                      Drug                                   
Name
Ocaratuzumab (USAN/INN)
Formula
C6464H10016N1712O2010S44
Exact mass
145192.1877
Mol weight
145281.90
Efficacy
Antineoplastic, Anti-CD20 antibody
  Type
Monoclonal antibody
Target
CD20 [HSA:931] [KO:K06466]
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    CD20
     D10482  Ocaratuzumab (USAN/INN)
Other DBs
CAS: 1169956-08-4
PubChem: 172232575
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system